![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/395 | |
A61K 31/5377 | |||
A61K 39/395 |
(11) | Number of the document | 2370103 |
(13) | Kind of document | T |
(96) | European patent application number | 09756754.9 |
Date of filing the European patent application | 2009-11-25 | |
(97) | Date of publication of the European application | 2011-10-05 |
(45) | Date of publication and mention of the grant of the patent | 2016-03-23 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2009/065861 |
Date | 2009-11-25 |
(87) | Number | WO 2010/060939 |
Date | 2010-06-03 |
(30) | Number | Date | Country code |
08170255 | 2008-11-28 | EP | |
08170261 | 2008-11-28 | EP |
(72) |
GARCIA-ECHEVERRIA, Carlos, CH
JENSEN, Michael, CH
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | PHARMACEUTICAL COMBINATIONS COMPRISING AN ISOXAZOLE DERIVED HSP90-INHIBITOR AND THE HER2 INHIBITOR TRASTUZUMAB |
PHARMACEUTICAL COMBINATIONS COMPRISING AN ISOXAZOLE DERIVED HSP90-INHIBITOR AND THE HER2 INHIBITOR TRASTUZUMAB |